PT - JOURNAL ARTICLE AU - Jensen, Jonas Brorson AU - Dollerup, Ole L. AU - Møller, Andreas B. AU - Billeskov, Tine B. AU - Dalbram, Emilie AU - Chubanava, Sabina AU - Dellinger, Ryan W. AU - Trost, Kajetan AU - Moritz, Thomas AU - Ringgaard, Steffen AU - Møller, Niels AU - Treebak, Jonas T. AU - Farup, Jean AU - Jessen, Niels TI - A randomized placebo-controlled clinical trial of Nicotinamide Riboside and Pterostilbene supplementation in experimental muscle injury in elderly subjects AID - 10.1101/2021.10.04.21264504 DP - 2021 Jan 01 TA - medRxiv PG - 2021.10.04.21264504 4099 - http://medrxiv.org/content/early/2021/10/05/2021.10.04.21264504.short 4100 - http://medrxiv.org/content/early/2021/10/05/2021.10.04.21264504.full AB - Background Maintenance and regeneration of functional skeletal muscle are dependent on a sufficient pool of muscle stem cells (MuSCs). During ageing there is a functional decline in this cellular pool which influences the regenerative capacity of skeletal muscle. Preclinical evidence have suggested that Nicotinamide Riboside (NR) and Pterostilbene (PT) can improve muscle regeneration e.g. by increasing MuSC function. The objective of the present study was to investigate if NRPT supplementation promotes skeletal muscle regeneration after muscle injury in elderly humans by improved recruitment of MuSCs.Methods In a randomized, double-blinded, placebo-controlled trial, 32 elderly men and women (55-80 yr) received daily supplementation with either NRPT (1000 mg NR + 200 mg PT) or matched placebo. Two weeks after initiation of supplementation, a skeletal muscle injury was applied in the vastus lateralis part of the quadriceps femoris muscle by electrically induced eccentric muscle work in a dynamometer. Skeletal muscle biopsies were obtained pre, 2h, 2, 8, and 30 days post injury. The main outcome of the study was change in MuSC content 8 days post injury.Results 31 enrolled subjects completed the entire protocol. The muscle work induced a substantial skeletal muscle injury in the study participants and was associated with release of myoglobin and creatine kinase, muscle soreness, tissue edema, and a decrease in muscle strength. MuSC content increased by 107% 8 days post injury (p= 0.0002) but with no effect of NRPT supplementation (p=0.58 for supplementation effect). MuSC proliferation and cell size revealed a large demand for recruitment post injury but was not affected by NRPT. Furthermore, histological analyses of muscle fiber area, internal nuclei and embryonic Myosin Heavy Chain showed no effect of NRPT supplementation.Conclusion Daily supplementation with 1000 mg NR + 200 mg PT is safe but does not improve recruitment of the MuSC pool or other measures of muscle recovery in response to injury or subsequent regeneration in elderly subjects.Competing Interest StatementRWD is employed by Elysium Health, New York, NY, USA and has stock options. Otherwise, there are no conflicts of interest to declareClinical TrialNCT03754842Funding StatementThis study was funded by grant from Novo Nordisk Foundation (Ref. NNF17OC0027242) given to JTT and NJ.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The local Research Ethics Committee in Central Denmark Region (1-10-72-301-18)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are available upon request.